Johnson & Johnson Eyes Protagonist: Biotech Buyout?
Update: 2025-10-10
Description
Johnson & Johnson eyes Protagonist Therapeutics! Shares surge as acquisition talks begin. What does this mean for the future of biotech and your investments? Tune in for the latest updates on this developing story.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
